Article Versions Notes

Suksamai D, Racha S, Sriratanasak N, Chaotham C, Aphicho K, Lin ACK, Chansriniyom C, Suwanborirux K, Chamni S, Chanvorachote P. 5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling. Marine Drugs. 2022; 20(4):235. https://doi.org/10.3390/md20040235

Suksamai, Darinthip, Satapat Racha, Nicharat Sriratanasak, Chatchai Chaotham, Kanokpol Aphicho, Aye Chan Khine Lin, Chaisak Chansriniyom, Khanit Suwanborirux, Supakarn Chamni, and Pithi Chanvorachote. 2022. "5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling" Marine Drugs 20, no. 4: 235. https://doi.org/10.3390/md20040235

Suksamai, D., Racha, S., Sriratanasak, N., Chaotham, C., Aphicho, K., Lin, A. C. K., Chansriniyom, C., Suwanborirux, K., Chamni, S., & Chanvorachote, P. (2022). 5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling. Marine Drugs, 20(4), 235. https://doi.org/10.3390/md20040235